Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and Therapies - Top-Institutions - MDSpire

Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and Therapies

  • By

  • Sarah A Boardman

  • Claire Hetherington

  • Thomas Hughes

  • Callum Cook

  • Ian Galea

  • Orla Hilton

  • Tom Solomon

  • Andrew D Luster

  • Stuart Allan

  • Evelyn Kurt-Jones

  • Joe Forth

  • Adjanie Patabendige

  • Franklyn N Egbe

  • Cordelia Dunai

  • Benedict D Michael

  • September 29, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neuroinfectious Diseases
    • Neuroimmunology
    • Blood-Brain Barrier Research

  • #2

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Neurovirology
    • Blood-Brain Barrier Biology
    • Neuroimmunology

  • #3

    Massachusetts General Hospital and Harvard Medical School
    Massachusetts General Hospital and Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neuroinfectious Diseases
    • Blood-Brain Barrier Research
    • Neuroimmunology

  • #4

    Washington University School of Medicine in St. Louis
    Washington University School of Medicine in St. Louis

    St. Louis, MO

    Key Differentiators

    • Neurovirology
    • Blood-Brain Barrier Biology
    • Neuroimmunology

  • #5

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Neuroinfectious Diseases
    • Blood-Brain Barrier Research
    • Neuroimmunology

Original Source(s)

Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and Therapies

  • by Sarah A Boardman, Claire Hetherington, Thomas Hughes, Callum Cook, Ian Galea, Orla Hilton, Tom Solomon, Andrew D Luster, Stuart Allan, Evelyn Kurt-Jones, Joe Forth, Adjanie Patabendige, Franklyn N Egbe, Cordelia Dunai, Benedict D Michael

  • September 29, 2025

Related Content

Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy

Case Report: Successful treatment of recurrent COVID-19 with intravenous immunoglobulin in a patient with rituximab-induced B-cell depletion and restoration of Fc-mediated effector functions

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing